Outlay

Award

ANTHIM (OBILTOXAXIMAB)

Recipient
ELUSYS THERAPEUTICS INC
Awarding agency
Department of Health and Human Services
Sub-agency
Office of Assistant Secretary for Preparedness and Response
Fiscal year
FY2024
Obligated (promised)
$124,523,123
Total obligation (detail)
$124,523,123
Potential value (ceiling)
$124,523,123
Outlaid (paid out, linked File C)
no linked financial data
Signed
Apr 30, 2024
Period of performance
May 1, 2024 – Dec 31, 2028
Competition
NOT COMPETED
Offers received
1
Solicitation
ONLY ONE SOURCE
Pricing
FIRM FIXED PRICE
NAICS
325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
Award type
DEFINITIVE CONTRACT

Transactions (8)

0Apr 30, 2024$69,250,063ANTHIM (OBILTOXAXIMAB)
P00001May 10, 2024OTHER ADMINISTRATIVE ACTION-$55,065,963DE-OBLIGATE FUNDS FROM CLIN 0001 AND 0004 TO REALIGN OBJECT CLASS CODES
P00002May 14, 2024OTHER ADMINISTRATIVE ACTION$55,065,963ANTHIM - RE-OBLIGATE FUNDS TO REALIGN OC
P00003Jul 23, 2025OTHER ADMINISTRATIVE ACTION$0ANTHIM - ASSIGNMENT OF CLAIMS
P00004Aug 22, 2025EXERCISE AN OPTION$55,273,060ANTHIM (OBILTOXAXIMAB)
P00005Jan 21, 2026SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE$0ANTHIM (OBILTOXAXIMAB)
P00006Jun 1, 2026OTHER ADMINISTRATIVE ACTION-$9,625,875ADMINISTRATIVE OBJECT CLASS CODE DEOBLIGATION-ANTHIM (OBILTOXAXIMAB)
P00007Jul 7, 2026OTHER ADMINISTRATIVE ACTION$9,625,875ADMINISTRATIVE OBJECT CLASS CODE CORRECTION-ANTHIM (OBILTOXAXIMAB)

Record history in our archive

Outlay keeps a content-hashed copy of this record from every pull. No post-publication revisions observed so far.

  • detailfirst capture